This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (158)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

David G. Cook, MD; Stanley Fahn, MD; Kenneth A. Brait, MD

Arch Neurol. 1974;30(1):59-64.

Abstract
Six men developed chronic manganese intoxication while employed in a manganese ore crushing plant. Symptoms included somnolence, gait imbalance, slurred speech, and impaired fine movements. Signs included bradykinesia, postural instability, impaired arising ability, masked facies, and speech disorder. One patient was exceptional in that his major symptoms did not develop until three years after leaving exposure.

Levodopa, up to 8 gm/day, was ineffective in three patients. Our cases and those in the literature indicate that, in the absence of rigidity or dystonia or both, levodopa is ineffective in chronic manganese intoxication.

Intravenous edetic acid (EDTA) infusions were followed by temporary improvement in four individuals. Increased urinary excretion of manganese during edetic acid infusion was observed in our cases and in two controls and thus does not appear to assist in diagnosing chronic manganese intoxication.

Author Affiliations
Philadelphia

From the Spiller Neurological Unit, Hospital of the University of Pennsylvania, Philadelphia.

Footnotes
Accepted for publication Aug 9, 1973.

Reprint request to Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia 19104 (Dr. Cook).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HYPERMANGANESEMIA, HEREDITARY HEMORRHAGIC TELANGIECTASIA, BRAIN ABSCESS: THE HEPATIC CONNECTION
Herrero Hernandez et al.
Neurology 2009;73:405-406.
FULL TEXT  

A Parkinsonian Syndrome in Methcathinone Users and the Role of Manganese
Stepens et al.
NEJM 2008;358:1009-1017.
ABSTRACT | FULL TEXT  

A Preliminary Study Revealing a New Association in Patients Undergoing Maintenance Hemodialysis: Manganism Symptoms and T1 Hyperintense Changes in the Basal Ganglia
da Silva et al.
Am. J. Neuroradiol. 2007;28:1474-1479.
ABSTRACT | FULL TEXT  

Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity
Klos et al.
Neurology 2006;67:1984-1989.
ABSTRACT | FULL TEXT  

Brain Accumulation and Toxicity of Mn(II) and Mn(III) Exposures
Reaney et al.
Toxicol Sci 2006;93:114-124.
ABSTRACT | FULL TEXT  

Searching for a relationship between manganese and welding and Parkinson's disease
Jankovic
Neurology 2005;64:2021-2028.
ABSTRACT | FULL TEXT  

Neurologic manifestations in welders with pallidal MRI T1 hyperintensity
Josephs et al.
Neurology 2005;64:2033-2039.
ABSTRACT | FULL TEXT  

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
Zecca et al.
Proc. Natl. Acad. Sci. USA 2004;101:9843-9848.
ABSTRACT | FULL TEXT  

Effect of levodopa treatment for parkinsonism in welders: A double-blind study
Koller et al.
Neurology 2004;62:730-733.
ABSTRACT | FULL TEXT  

Dietary Manganese Intake and Type of Lipid Do Not Affect Clinical or Neuropsychological Measures in Healthy Young Women
Finley et al.
J. Nutr. 2003;133:2849-2856.
ABSTRACT | FULL TEXT  

Welding-related parkinsonism: Clinical features, treatment, and pathophysiology
Racette et al.
Neurology 2001;56:8-13.
ABSTRACT | FULL TEXT  

In vitro and in vivo studies on chelation of manganese
Missy et al.
Hum Exp Toxicol 2000;19:448-456.
ABSTRACT  

Chronic Manganese Intoxication
Huang et al.
Arch Neurol 1989;46:1104-1106.
ABSTRACT  

Pathogenesis of Parkinson's Disease
Mann and Yates
Arch Neurol 1982;39:545-549.
ABSTRACT